PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933299
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933299
The global coronary stents market was valued at USD 7.02 billion in 2025 and is projected to grow from USD 7.38 billion in 2026 to USD 12.26 billion by 2034, registering a CAGR of 6.54% during 2026-2034. North America dominated the market in 2025 with a 33.55% share, supported by robust healthcare infrastructure, high prevalence of coronary artery diseases (CAD), and frequent product launches backed by regulatory approvals.
Coronary stents are small, tube-shaped devices inserted into coronary arteries to keep them open, primarily used in Percutaneous Coronary Interventions (PCI) to treat conditions like atherosclerosis. The rising global incidence of cardiovascular diseases, technological advancements in stenting procedures, and improved accuracy in PCI operations are driving adoption in both developed and emerging markets.
MARKET DRIVERS
Rising Prevalence of Coronary Heart Disease
The growing prevalence of coronary heart disorders globally is a key market driver. Sedentary lifestyles, stress, and unhealthy eating habits are contributing factors. According to the U.S. CDC, about 5% of adults aged 20+ had CAD in 2023, highlighting a significant patient pool driving demand for stents. Additionally, the aging global population, more prone to CAD, further propels market growth.
Technological Advancements
Innovations in stent design, such as drug-eluting stents (DES) and bioresorbable stents, have enhanced safety and clinical outcomes. Devices like Medtronic's Onyx Frontier DES (FDA approved in 2022) feature improved delivery systems, facilitating complex PCI procedures. Minimally invasive interventions, reduced restenosis rates, and enhanced stent flexibility are increasing adoption among cardiologists worldwide.
MARKET RESTRAINTS
Side Effects and Regulatory Barriers
Complications like arterial damage, allergic reactions, or restenosis can hinder adoption. Strict regulatory approvals also limit product entry in certain regions. Product recalls, such as Atrium Medical's iCast-covered stents in 2022, negatively impact patient trust and market expansion.
MARKET OPPORTUNITIES
Emerging regions present significant growth potential due to rising awareness of cardiovascular diseases, expansion of specialty hospitals, and establishment of catheterization labs. Initiatives like India's public heart health campaigns (2023) and hospital expansions in Australia and India in 2024 demonstrate increasing accessibility and awareness, creating opportunities for stent adoption.
MARKET TRENDS
Continuous innovations in coronary stents, including reducing strut thickness, improving flexibility, and introducing biodegradable polymers, are shaping market growth. Examples include Medinol's EluNIR-PERL DES, FDA approved in 2023, enhancing patient outcomes and procedural efficiency.
SEGMENTATION ANALYSIS
By Stent Type
By Material
By Deployment
By Application
By End-User
REGIONAL OUTLOOK
COMPETITIVE LANDSCAPE
Key players include Abbott, Medtronic, Boston Scientific, BIOTRONIK, Terumo, MicroPort, B. Braun SE, Stentys, Meril Life Sciences, and Relisys Medical. Strategic acquisitions, regulatory approvals, and clinical trials are the primary growth strategies. Notable developments: Abbott acquiring CSI in 2023 and MicroPort receiving NMPA approval for Firesorb in 2024.
CONCLUSION
The global coronary stents market is projected to grow steadily from USD 7.02 billion in 2025 to USD 12.26 billion by 2034, driven by rising CAD prevalence, technological advancements in stent design, and expansion of healthcare infrastructure worldwide. While procedural risks, regulatory barriers, and product recalls pose challenges, innovations such as drug-eluting, bioresorbable, and self-expandable stents, coupled with emerging regional opportunities, ensure a robust growth trajectory. North America maintains dominance, while Asia Pacific exhibits the highest growth potential, creating significant opportunities for both established and emerging market players.
Segmentation Stent Type, Material Type, Deployment, Application, End-user, and Region
By Stent Type * Drug Eluting Stent
By Material Type * Metal
By Deployment * Self-expandable
By Application * Acute Coronary Syndrome (ACS)
By End-user * Hospitals & ASCs
By Region * North America (By Stent Type, Material Type, Deployment, Application, End-user, and Country)